← Back to Search

N95 Style Transparent Face Mask

CrystalGuard for Respiratory Infection

N/A
Waitlist Available
Led By Peter Chai, MD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* \>18 years old
* No history of asthma, restrictive lung disease, interstitial lung disease, or emphysema
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after completion of all three arms
Awards & highlights

Summary

Face masks have become a critically important public health intervention after the COVID-19 pandemic. Multiple types of masks ranging from full face filtering to cloth masks have been developed and commercialized to facilitate protection against respiratory pathogens. Most of these systems are made with opaque fabrics and may prevent individuals from expressing emotions or for those who are deaf and hard of hearing, communicating. To date, few transparent face masks which also confer respiratory pathogen protection have been developed. This study will test the feasability and acceptability of two new masks, the SEEUS-95 mask and CrystalGuard mask which are both transparent versions of N-95 filtering face masks.

Who is the study for?
This trial is for individuals who are interested in testing the feasibility and acceptability of two new transparent face masks designed to protect against respiratory pathogens like COVID-19. Specific eligibility criteria were not provided.
What is being tested?
The study is comparing the traditional N95 face mask with two novel transparent masks: CrystalGuard Mask and SEEUS95 Transparent mask, to assess their effectiveness and user experience.
What are the potential side effects?
Potential side effects may include discomfort, skin irritation, or difficulty breathing due to mask fit. However, specific side effects related to these particular masks have not been detailed.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after mask wearing
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after mask wearing for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability
Secondary study objectives
Mask preference

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: SEEUS95Experimental Treatment1 Intervention
Transparent mask developed by SEEUS95
Group II: CrystalGuardExperimental Treatment1 Intervention
Transparent mask developed at BWH
Group III: N95Active Control1 Intervention
Standard N95 face mask

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,631 Previous Clinical Trials
11,475,273 Total Patients Enrolled
Peter Chai, MDPrincipal InvestigatorBrigham and Women's Hospital
~27 spots leftby Apr 2025